Targeting MITF in the tolerance-phase
Oncotarget
.
2016 Aug 23;7(34):54094-54095.
doi: 10.18632/oncotarget.9423.
Authors
Imanol Arozarena
,
Michael P Smith
,
Claudia Wellbrock
1
Affiliation
1
Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Manchester, UK.
PMID:
27528022
PMCID:
PMC5342328
DOI:
10.18632/oncotarget.9423
No abstract available
Keywords:
BRAF; HIV-protease; MITF; melanoma; therapy resistance.
Publication types
Editorial
Comment
MeSH terms
Drug Tolerance
Humans
Melanoma*
Proto-Oncogene Proteins B-raf
Substances
Proto-Oncogene Proteins B-raf
Grants and funding
16416/CRUK_/Cancer Research UK/United Kingdom